Recent Updates
Recently added Catalysts
PYPD Positive Sentiment Score: 60/100

polypid Ltd. Notice of ANNUAL and EXTRAORDINARY General Meeting of shareholders to be held on

Key Takeaway: PolyPid Ltd. announced its Annual and Extraordinary General Meeting scheduled for May 5, 2023. Shareholders will vote on several key resolutions, including the re-election of board members, executive compensation, and amendments to the company's Articles of Association. Shareholders of record are entitled to participate in the meeting, either in person or via proxy. The meeting's agenda aims to enhance corporate governance and maintain transparency with shareholders regarding financial operations.

Market Sentiment Analysis

POSITIVE FACTORS

  • The Company is holding an Annual and Extraordinary General Meeting, indicating ongoing corporate governance.
  • Shareholders are invited to participate in key decisions regarding the Board and executive compensation.
  • The agenda includes financial discussions, which reflects transparency in financial management.

CONCERNS & RISKS

  • Potential difficulties in shareholder engagement if they miss the proxy submission deadline.
  • Shareholders must provide identification and legal documents to vote if shares are held in street name, which could complicate participation.

Full Press Release Details

of ANNUAL and EXTRAORDINARY General Meeting of shareholders
Notice is hereby given that an Annual and Extraordinary
General Meeting of Shareholders (the "Meeting") of PolyPid Ltd. ("PolyPid" or the "Company")
will be held on May 5, 2023 at 2:00 p.m. Israel time at the Company's office, located at 18 Hasivim Street, Petach Tikva 495376,
Israel, for the following purposes:
1. To re-elect Kost Forer Gabbay & Kasierer, Certified Public Accountants, as the independent registered public accountants of the Company, and to authorize the board of directors of the Company to determine their compensation, until the next annual general meeting of the Company's shareholders.
2. To re- elect eight members of the board of directors of the Company and approve their compensation.
3. To approve an option grant for the Company's Chief Executive Officer, Ms. Dikla Czaczkes Akselbrad.
4. To approve repricing of options for the Company's Chief Executive Officer, Ms. Dikla Czaczkes Akselbrad.
5. To approve repricing of options for the members of the board of directors of the Company.
6. To approve an extension of the Company's U.S. subplan under Company's Amended and Restated 2012 Share Option Plan for U.S. tax purposes.
7. To increase the Company's authorized share capital and to amend and restate the Company's Articles of Association to reflect the same.
8. To approve an amendment to the Articles of Association of the Company to include an Exclusive Forum' section.
9. To discuss the Company's financial statements for the fiscal year ended December 31, 2022.
Our board of directors (the "Board of
Directors") recommends that you vote in favor of the proposed resolutions, which are described in the attached proxy statement.
Shareholders of record at the close of business
on April 5, 2023 (the "Record Date"), are entitled to notice of and to vote at the Meeting, either in person or by
appointing a proxy to vote in their stead at the Meeting (as detailed below).
Shareholders may revoke their proxies or voting
instruction form (as applicable) in accordance with Section 9 of the Israeli Companies Law, 5759-1999 regulations (proxy and positions
A form of proxy for use at the Meeting, as attached
to the proxy statement, together with a return envelope, will be sent to holders of the Company's ordinary shares, no par value
(the "Ordinary Shares"). By appointing "proxies," shareholders may vote at the Meeting whether or not they
attend. If a properly executed proxy in the attached form is received by the Company at least 4 hours prior to the Meeting, all of the
Ordinary Shares represented by the proxy shall be voted as indicated on the form. Subject to applicable law and the rules of the Nasdaq
Stock Market, in the absence of instructions, the Ordinary Shares represented by properly executed and received proxies will be voted
"FOR" all of the proposed resolutions to be presented at the Meeting for which the Board of Directors recommends a "FOR".
Shareholders may revoke their proxies or voting instruction form (as applicable) at any time before the deadline for receipt of proxies
or voting instruction form (as applicable) by filing with the Company (in the case of holders of Ordinary Shares) a written notice of
revocation or duly executed proxy or voting instruction form (as applicable) bearing a later date.
If your shares are registered directly in your
name with our transfer agent, American Stock Transfer & Trust Company, LLC, you are considered, with respect to those shares, the
shareholder of record. In such case, these proxy materials are being sent directly to you. As the shareholder of record, you have the
right to use the proxy card included with this proxy statement to grant your voting proxy directly to Mr. Tal Vilnai, Secretary and General
Counsel of the Company and Orna Blum, Assistant Secretary and Legal Counsel of the Company, or to vote in person at the Meeting.
If your shares are held through a bank, broker
or other nominee, they are considered to be held in "street name" and you are the beneficial owner with respect to those shares.
A beneficial owner as of the Record Date has the right to direct the bank, broker or nominee how to vote shares held by such beneficial
owner at the Meeting, and must also provide the Company with a copy of their identity card, passport or certification of incorporation,
as the case may be. If your shares were held in "street name," as of the Record Date, these proxy materials are being forwarded
to you by your bank, broker or nominee who is considered, with respect to those shares, as the shareholder of record, together with a
voting instruction card for you to use in directing the bank, broker or nominee how to vote your shares. You also may attend the Meeting.
Because a beneficial owner is not a shareholder of record, you may not vote those shares directly at the Meeting unless you obtain a "legal
proxy" from the bank, broker or other nominee that holds your shares directly, giving you the right to vote the shares at the Meeting.
Brokers who hold shares in "street name" for clients typically have authority to vote on "routine" proposals even
when they have not received instructions from beneficial owners. Proposals No. 1 and 7 on the agenda of the Meeting are considered routine.
Absent specific instructions from the beneficial owner of the shares, brokers are not allowed to exercise their voting discretion, among
other things, with respect to the election of directors or any matter that relates to executive compensation; and therefore, a "broker
non-vote" occurs with respect to such uninstructed shares. Therefore, it is important for a shareholder that holds Ordinary Shares
through a bank or broker to instruct its bank or broker how to vote its shares, if the shareholder wants its shares to count for all proposals.
Sincerely,
Jacob Harel
Chairman of the Board of Directors
March 31, 2023

Frequently Asked Questions

When will the PolyPid Annual Meeting take place?

The PolyPid Annual Meeting is scheduled for May 5, 2023, at 2:00 p.m. Israel time.

What is the location of PolyPid's Meeting?

The Meeting will be held at 18 Hasivim Street, Petach Tikva, Israel.

Who can vote at the PolyPid Meeting?

Shareholders of record as of April 5, 2023, can vote in person or by proxy.

What key proposals will be discussed at the Meeting?

Key proposals include board member re-elections, option grants, and financial statements.

How can shareholders revoke their proxy votes?

Shareholders can revoke their proxy by providing written notice or a later-dated proxy.

Last updated: Mar 31, 2023